E1	Modifier:T1 Modifies:T104
E3	Modifier:T3 Modifies:T104
E4	Condition:T4 Name:T104
E5	Condition:T5 Name:T105
E7	Eq-Comparison:T7 Operator:T106 Value:T107
E8	Procedure:T8 Minimum-Count:E7 Temporality:E6
E9	Negation:T9 Negates:E10
E10	Condition:T10 Name:T179
E11	Condition:T11 Name:T109
E13	Eq-Comparison:T13 Value:T110 Unit:T111 Operator:T112
E17	Condition:T17 Name:T15
E18	Condition:T18 Name:T115
E19	Condition:T19 Name:T116
E20	Condition:T20 Name:T117
E22	Condition:T22 Name:T118
E23	Modifier:T23 Modifies:T119
E24	Condition:T24 Name:T119
E25	Condition:T25 Name:T120
E26	Observation:T26 Name:T121 Numeric-Filter:E27 Temporality:E28
E27	Eq-Comparison:T27 Operator:T122 Value:T123 Per:T114
E28	Eq-Comparison:T28 Operator:T124 Value:T125 Temporal-Unit:T126
E30	Eq-Comparison:T30 Temporal-Recency:T127
E31	Procedure:T31 Temporality:E30
E32	Drug:T32 Name:T128
E35	Observation:T35 Name:T33 Numeric-Filter:E36
E36	Eq-Comparison:T36 Operator:T129 Value:T130 Per:T34
E38	Eq-Comparison:T38 Temporal-Recency:T181
E39	Procedure:T39 Temporality:E38
E41	Observation:T41 Name:T131 Numeric-Filter:E42
E42	Eq-Comparison:T42 Operator:T182 Value:T183
E43	Observation:T43 Name:T132 Numeric-Filter:E45
E45	Eq-Comparison:T45 Value:T134 Unit:T135 Per:T136
E46	Observation:T46 Name:T137 Numeric-Filter:E49
E48	Observation:T48 Name:T138 Numeric-Filter:E49
E49	Eq-Comparison:T49 Operator:T139 Value:T140 Unit:T44
E50	Observation:T50 Name:T141 Numeric-Filter:E51
E51	Eq-Comparison:T51 Operator:T142 Value:T143 Unit:T184
E52	Eq-Comparison:T52 Temporal-Period:T144
E53	Modifier:T53 Modifies:T145
E54	Condition:T54 Name:T145 Temporality:E52
E55	Condition:T55 Name:T146
E58	Modifier:T58 Modifies:T148
E60	Condition:T60 Name:T148
E62	Observation:T62 Name:T149 Polarity:T147
E63	Eq-Comparison:T63 Temporal-Period:T150
E66	Drug:T66 Name:T152 Temporality:E63 Dose:T61 Dose2:T151 Temporality2:E67
E67	Eq-Comparison:T67 Operator:T153 Value:T154 Temporal-Unit:T155
E69	Eq-Comparison:T69 Temporal-Recency:T156
E70	Study:T70 Study-Of:E71
E71	Procedure:T71 Temporality:E69
E72	Eq-Comparison:T72 Temporal-Period:T157
E73	Procedure:T73 Name:T158 Temporality:E72 Severity:T159 Polarity:T160
E75	Modifier:T75 Modifies:T158
E76	Condition:T76 Name:T162 Severity:T161
E77	Eq-Comparison:T77 Temporal-Period:T163
E78	Modifier:T78 Modifies:T165
E79	Condition:T79 Name:T165 Severity:T164 Temporality:E77
E80	Other:T80 Is-Other:E82
E81	Modifier:T81
E82	Condition:T82 Name:T166 Temporality:E83
E83	Eq-Comparison:T83 Operator:T167 Value:T168 Temporal-Unit:T169
E85	Study:T85
E86	Condition:T86 Name:T170
E87	Assertion:T87 Asserted:E88
E88	Negation:T88 Negates:E89
E89	Study:T89
E90	Eq-Comparison:T90 Temporal-Period:T171
E91	Modifier:T91 Modifies:T172
E92	Procedure:T92 Name:T172 Temporality:E90
E93	Eq-Comparison:T93 Temporal-Period:T173
E94	Procedure:T94 Temporality:E93
E95	Procedure:T95 Name:T174
E97	Negation:T97 Negates:E98
E98	Condition:T98 Name:T175
E100	Eq-Comparison:T100 Temporal-Period:T176
E101	Procedure:T101 Name:T177 Temporality:E100
E103	Procedure:T103 Name:T178 Temporality:E100
E6	Eq-Comparison:T6 Temporal-Period:T108
E12	Observation:T12 Name:T14 Specimen:T113 Numeric-Filter:E13
E14	Assertion:T40 Asserted:E32
E15	Modifier:T57 Modifies:T148
E33	Modifier:T65 Modifies:T158
E34	Negation:T74 Negates:E81
T1	Modifier 25 35	Refractory
T3	Modifier 39 47	relapsed
T4	Condition 48 51	AML
T5	Condition 82 100	Refractory disease
T7	Eq-Comparison 120 130	at least 1
T8	Procedure 137 146	treatment
T9	Negation 152 154	no
T10	Condition 155 164	remission
T11	Condition 176 192	Relapsed disease
T13	Eq-Comparison 212 222	5% or more
T17	Condition 256 265	remission
T18	Condition 291 294	AML
T19	Condition 308 333	myelodysplastic syndromes
T20	Condition 345 349	CMML
T22	Condition 354 382	myeloproliferative neoplasms
T23	Modifier 384 393	secondary
T24	Condition 394 397	AML
T25	Condition 399 405	ts-AML
T26	Observation 431 454	Circulating blast count
T27	Eq-Comparison 455 463	≤ 200/μL
T28	Eq-Comparison 464 478	within 10 days
T30	Eq-Comparison 488 493	first
T31	Procedure 503 512	treatment
T32	Drug 514 525	Hydroxyurea
T35	Observation 553 575	peripheral blast count
T36	Eq-Comparison 576 584	≤ 200/μL
T38	Eq-Comparison 595 604	first day
T39	Procedure 617 626	treatment
T41	Observation 669 673	ECOG
T42	Eq-Comparison 674 677	≤ 2
T43	Observation 683 713	Estimated creatinine clearance
T45	Eq-Comparison 714 725	≥ 50 mL/min
T46	Observation 731 734	AST
T48	Observation 739 742	ALT
T49	Eq-Comparison 743 754	≤ 3.0 x ULN
T50	Observation 760 769	Bilirubin
T51	Eq-Comparison 770 781	≤ 3.0 x ULN
T52	Eq-Comparison 807 813	Active
T53	Modifier 814 817	CNS
T54	Condition 818 826	Leukemia
T55	Condition 839 852	HIV infection
T58	Modifier 862 873	hepatitis B
T60	Condition 889 898	infection
T62	Observation 918 928	viral load
T63	Eq-Comparison 952 960	received
T66	Drug 984 998	CYP3A inducers
T67	Eq-Comparison 999 1012	within 7 days
T69	Eq-Comparison 1026 1036	initiation
T70	Study 1040 1045	study
T71	Procedure 1046 1055	treatment
T72	Eq-Comparison 1067 1081	received prior
T73	Procedure 1082 1091	radiation
T75	Modifier 1145 1150	organ
T76	Condition 1180 1195	cardiac disease
T77	Eq-Comparison 1202 1208	Active
T78	Modifier 1210 1222	uncontrolled
T79	Condition 1231 1240	infection
T80	Other 1252 1257	other
T81	Modifier 1262 1269	myeloid
T82	Condition 1270 1280	malignancy
T83	Eq-Comparison 1281 1295	within 2 years
T85	Study 1299 1304	entry
T86	Condition 1329 1349	Psychiatric disorder
T87	Assertion 1355 1360	would
T88	Negation 1361 1369	preclude
T89	Study 1370 1375	study
T90	Eq-Comparison 1395 1403	Previous
T91	Modifier 1404 1409	solid
T92	Procedure 1410 1426	organ transplant
T93	Eq-Comparison 1428 1433	prior
T94	Procedure 1434 1443	treatment
T95	Procedure 1449 1452	SCT
T97	Negation 1468 1471	not
T98	Condition 1487 1491	GVHD
T100	Eq-Comparison 1504 1513	receiving
T101	Procedure 1514 1531	immunosuppression
T103	Procedure 1532 1544	GVHD therapy
T104	Condition-Name 48 51	AML
T105	Condition-Name 82 100	Refractory disease
T106	Eq-Operator 120 128	at least
T107	Eq-Value 129 130	1
T108	Eq-Temporal-Period 131 136	prior
T109	Condition-Name 176 192	Relapsed disease
T110	Eq-Value 212 213	5
T111	Eq-Unit 213 214	%
T112	Eq-Operator 215 222	or more
T115	Condition-Name 291 294	AML
T116	Condition-Name 308 333	myelodysplastic syndromes
T117	Condition-Name 345 349	CMML
T118	Condition-Name 354 382	myeloproliferative neoplasms
T119	Condition-Name 394 397	AML
T120	Condition-Name 399 405	ts-AML
T121	Observation-Name 431 454	Circulating blast count
T122	Eq-Operator 455 456	≤
T123	Eq-Value 457 460	200
T124	Eq-Operator 464 470	within
T125	Eq-Value 471 473	10
T126	Eq-Temporal-Unit 474 478	days
T127	Eq-Temporal-Recency 488 493	first
T128	Drug-Name 514 525	Hydroxyurea
T129	Eq-Operator 576 577	≤
T130	Eq-Value 578 581	200
T131	Observation-Name 669 673	ECOG
T132	Observation-Name 683 713	Estimated creatinine clearance
T133	Eq-Operator 714 715	≥
T134	Eq-Value 716 718	50
T135	Eq-Unit 719 721	mL
T136	Eq-Temporal-Unit 722 725	min
T137	Observation-Name 731 734	AST
T138	Observation-Name 739 742	ALT
T139	Eq-Operator 743 744	≤
T140	Eq-Value 745 748	3.0
T141	Observation-Name 760 769	Bilirubin
T142	Eq-Operator 770 771	≤
T143	Eq-Value 772 775	3.0
T144	Eq-Temporal-Period 807 813	Active
T145	Condition-Name 818 826	Leukemia
T146	Condition-Name 839 852	HIV infection
T148	Condition-Name 889 898	infection
T149	Observation-Name 918 928	viral load
T150	Eq-Temporal-Period 952 960	received
T151	Polarity 975 983	moderate
T152	Drug-Name 984 998	CYP3A inducers
T153	Eq-Operator 999 1005	within
T154	Eq-Value 1006 1007	7
T155	Eq-Temporal-Unit 1008 1012	days
T156	Eq-Temporal-Recency 1026 1036	initiation
T157	Eq-Temporal-Period 1067 1081	received prior
T158	Procedure-Name 1082 1091	radiation
T159	Severity 1129 1137	critical
T160	Polarity 1138 1144	normal
T161	Severity 1168 1179	significant
T162	Condition-Name 1180 1195	cardiac disease
T163	Eq-Temporal-Period 1202 1208	Active
T164	Severity 1223 1230	serious
T165	Condition-Name 1231 1240	infection
T166	Condition-Name 1270 1280	malignancy
T167	Eq-Operator 1281 1287	within
T168	Eq-Value 1288 1289	2
T169	Eq-Temporal-Unit 1290 1295	years
T170	Condition-Name 1329 1349	Psychiatric disorder
T171	Eq-Temporal-Period 1395 1403	Previous
T172	Procedure-Name 1410 1426	organ transplant
T173	Eq-Temporal-Period 1428 1433	prior
T174	Procedure-Name 1449 1452	SCT
T175	Condition-Name 1487 1491	GVHD
T176	Eq-Temporal-Period 1504 1513	receiving
T177	Procedure-Name 1514 1531	immunosuppression
T178	Procedure-Name 1532 1544	GVHD therapy
T6	Eq-Comparison 131 136	prior
T179	Condition-Name 155 164	remission
T12	Observation 223 244	blasts in bone marrow
T14	Observation-Name 223 229	blasts
T113	Specimen 233 244	bone marrow
T15	Condition-Name 256 265	remission
T114	Eq-Unit 461 463	μL
T33	Observation-Name 553 575	peripheral blast count
T34	Eq-Unit 582 584	μL
T181	Eq-Temporal-Recency 595 604	first day
T40	Assertion 526 540	should be used
T182	Eq-Operator 674 675	≤
T183	Eq-Value 676 677	2
T44	Eq-Unit 751 754	ULN
T184	Eq-Unit 778 781	ULN
T57	Modifier 877 888	hepatitis C
T147	Polarity 907 917	detectable
T61	Polarity 961 967	strong
T65	Modifier 1095 1121	maximally tolerated levels
T74	Negation 1258 1261	non
A12	Assertion-Type-Value E87 hypothetical
A13	Eq-Operator-Value T106 GTEQ
A14	Eq-Temporal-Period-Value T108 past
A15	Eq-Operator-Value T112 GTEQ
A17	Observation-Type-Value E26 lab
A18	Eq-Operator-Value T122 LTEQ
A19	Eq-Operator-Value T124 LTEQ
A20	Eq-Temporal-Unit-Value T126 day
A21	Eq-Temporal-Recency-Value T127 first-time
A22	Eq-Operator-Value T129 LTEQ
A23	Observation-Type-Value E43 lab
A24	Eq-Operator-Value T133 GTEQ
A25	Eq-Temporal-Unit-Value T136 minute
A26	Observation-Type-Value E46 lab
A27	Observation-Type-Value E48 lab
A28	Eq-Operator-Value T139 LTEQ
A29	Observation-Type-Value E50 lab
A30	Eq-Operator-Value T142 LTEQ
A31	Eq-Temporal-Period-Value T144 present
A32	Observation-Type-Value E62 lab
A33	Eq-Temporal-Period-Value T150 past
A35	Eq-Operator-Value T153 LTEQ
A36	Eq-Temporal-Unit-Value T155 day
A37	Eq-Temporal-Recency-Value T156 first-time
A38	Eq-Temporal-Period-Value T157 past
A39	Severity-Value T159 severe
A40	Polarity-Value T160 normal
A41	Severity-Value T161 severe
A42	Eq-Temporal-Period-Value T163 present
A43	Severity-Value T164 severe
A44	Eq-Operator-Value T167 LTEQ
A45	Eq-Temporal-Unit-Value T169 year
A46	Eq-Temporal-Period-Value T171 past
A47	Eq-Temporal-Period-Value T173 past
A48	Eq-Temporal-Period-Value T176 present
A1	Observation-Type-Value E12 lab
A2	Observation-Type-Value E35 lab
A3	Eq-Temporal-Recency-Value T181 first-time
A6	Assertion-Type-Value E14 hypothetical
A7	Eq-Operator-Value T182 LTEQ
A9	Polarity-Value T147 positive
A49	Polarity-Value T151 medium
A16	Polarity-Value T61 high
R1	Equivalent-To Arg1:E8 Arg2:E5
R2	Equivalent-To Arg1:E12 Arg2:E11
R3	Caused-By Arg1:E18 Arg2:E19
R4	Abbrev-Of Arg1:E20 Arg2:E19
R5	Caused-By Arg1:E18 Arg2:E22
R6	Abbrev-Of Arg1:E24 Arg2:E22
R7	Abbrev-Of Arg1:E25 Arg2:E22
R8	Caused-By Arg1:E35 Arg2:E32
R9	Found-By Arg1:E60 Arg2:E62
R10	Found-By Arg1:E55 Arg2:E62
R11	Caused-By Arg1:E88 Arg2:E86
R12	Using Arg1:E94 Arg2:E95
R13	Or Arg1:E1 Arg2:E3
R14	After Arg1:E12 Arg2:E17
R15	Or Arg1:E20 Arg2:E22
R16	Before Arg1:E28 Arg2:E30
R17	Before Arg1:E32 Arg2:E38
R18	And Arg1:E46 Arg2:E48
R19	Or Arg1:E55 Arg2:E60
R20	Or Arg1:E58 Arg2:E15
R21	Or Arg1:T61 Arg2:T151
R22	Before Arg1:E67 Arg2:E69
R23	Before Arg1:E83 Arg2:E85
R24	And Arg1:E95 Arg2:E97
R25	Or Arg1:E98 Arg2:E101
R26	Or Arg1:E101 Arg2:E103
R27	And Arg1:E8 Arg2:E9
R28	Or Arg1:E24 Arg2:E25